![Shloma Yanai, CEO of Teva Pharmaceutical Industries Ltd. reacts during a news conference in Cologne March 18, 2010. Teva Pharmaceutical on Thursday bought German generic pharma maker Ratiopharm for 3.625 billion euros. Shloma Yanai, CEO of Teva Pharmaceutical Industries Ltd. reacts during a news conference in Cologne March 18, 2010. Teva Pharmaceutical on Thursday bought German generic pharma maker Ratiopharm for 3.625 billion euros.](https://l450v.alamy.com/450v/2d24j7y/shloma-yanai-ceo-of-teva-pharmaceutical-industries-ltd-addresses-a-news-conference-in-cologne-march-18-2010-teva-pharmaceutical-on-thursday-bought-german-generic-pharma-maker-ratiopharm-for-3625-billion-euros-reuterswolfgang-rattay-germany-tags-business-2d24j7y.jpg)
Shloma Yanai, CEO of Teva Pharmaceutical Industries Ltd. reacts during a news conference in Cologne March 18, 2010. Teva Pharmaceutical on Thursday bought German generic pharma maker Ratiopharm for 3.625 billion euros.
![Shloma Yanai, CEO of Teva Pharmaceutical Industries Ltd. collects his papers following a news conference in Cologne March 18, 2010. Teva Pharmaceutical on Thursday bought German generic pharma maker Ratiopharm for 3.625 Shloma Yanai, CEO of Teva Pharmaceutical Industries Ltd. collects his papers following a news conference in Cologne March 18, 2010. Teva Pharmaceutical on Thursday bought German generic pharma maker Ratiopharm for 3.625](https://c8.alamy.com/comp/2D1WY6T/shloma-yanai-ceo-of-teva-pharmaceutical-industries-ltd-collects-his-papers-following-a-news-conference-in-cologne-march-18-2010-teva-pharmaceutical-on-thursday-bought-german-generic-pharma-maker-ratiopharm-for-3625-billion-euros-reuterswolfgang-rattay-germany-tags-business-2D1WY6T.jpg)
Shloma Yanai, CEO of Teva Pharmaceutical Industries Ltd. collects his papers following a news conference in Cologne March 18, 2010. Teva Pharmaceutical on Thursday bought German generic pharma maker Ratiopharm for 3.625
![Shloma Yanai, CEO of Teva Pharmaceutical Industries Ltd. reacts during a news conference in Cologne March Shloma Yanai, CEO of Teva Pharmaceutical Industries Ltd. reacts during a news conference in Cologne March](https://l450v.alamy.com/450v/2d2axtn/shloma-yanai-ceo-of-teva-pharmaceutical-industries-ltd-reacts-during-a-news-conference-in-cologne-march-18-2010-teva-pharmaceutical-on-thursday-bought-german-generic-pharma-maker-ratiopharm-for-3625-billion-euros-reuterswolfgang-rattay-germany-tags-business-headshot-2d2axtn.jpg)